UBS O'Connor’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-272,147
Closed -$20.5M 311
2017
Q4
$20.5M Buy
272,147
+63,561
+30% +$4.64M 0.36% 60
2017
Q3
$15.2M Buy
+208,586
New +$15M 0.22% 94
2015
Q4
Sell
-37,496
Closed -$2.38M 443
2015
Q3
$2.38M Buy
+37,496
New +$2.45M 0.02% 342
2015
Q1
Sell
-520,316
Closed -$36M 774
2014
Q4
$36M Buy
520,316
+210,316
+68% +$14.2M 0.63% 38
2014
Q3
$20.2M Sell
310,000
-67,599
-18% -$4.46M 0.35% 84
2014
Q2
$25.7M Sell
377,599
-114,454
-23% -$7.67M 0.16% 55
2014
Q1
$31.9M Buy
492,053
+209,487
+74% +$13.2M 0.6% 44
2013
Q4
$18.4M Sell
282,566
-719,932
-72% -$46.1M 0.34% 107
2013
Q3
$59.4M Buy
+1,002,498
New +$59.4M 1.24% 11

Other funds holding CL

UBS O'Connor's CL Position: Q1 2018 in Review

UBS O'Connor sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 272,147 shares — an estimated $20.5M sold.

UBS O'Connor first reported a position in CL in Q3 2013 and held it in 9 quarters. The position peaked at $59.4M in Q3 2013. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

  • UBS O'Connor reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
  • UBS O'Connor sold 272,147 Colgate-Palmolive shares in Q1 2018, an estimated $20.5M.
  • UBS O'Connor first reported a position in Colgate-Palmolive in Q3 2013 and held it in 9 quarters.
  • UBS O'Connor's Colgate-Palmolive position peaked at $59.4M in Q3 2013.
  • 1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on UBS O'Connor's 13F filing for Q1 2018, filed 14 May 2018.